Nevertheless, our work suggests that therapeutic strategies targeting GABAergic signaling polarity in brain may be useful in reducing SUDEP risk in SCN1A- and SCN1B-DS. This evidence concerns the gene SCN1A and Sudden unexpected death in epilepsy.